The water, DNA, collagen and noncollagen protein contents in embryos after maternal administration of a teratogenic dose of phenytoin

Toxicol Lett. 1985 Apr;25(1):41-6. doi: 10.1016/0378-4274(85)90098-0.

Abstract

The growth of developing A/J mouse embryos was studied after maternal administration of phenytoin (Dilantin), an anticonvulsant drug. Wet weight, dry weight, protein and DNA contents of the embryos were quantitated 24 h after drug administration. Collagen content was investigated because of its importance in cellular differentiation. The wet and dry weight of embryos from phenytoin-treated mothers were 52.3 and 57.5%, respectively, of that of embryos of control mothers. DNA and protein contents were also decreased in embryos from phenytoin-treated mothers. Collagen represented only 0.07% of the protein present in day 11 control embryos, but was increased 4.9-fold in embryos from phenytoin-treated mothers in comparison to controls. These results suggest that phenytoin reduces overall embryonic growth but stimulates collagen synthesis.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Collagen / metabolism*
  • DNA / metabolism*
  • Embryo, Mammalian / drug effects*
  • Embryo, Mammalian / metabolism
  • Embryonic and Fetal Development / drug effects
  • Female
  • Maternal-Fetal Exchange
  • Mice
  • Mice, Inbred A
  • Phenytoin / toxicity*
  • Pregnancy
  • Proteins / metabolism*
  • Teratogens

Substances

  • Proteins
  • Teratogens
  • Phenytoin
  • Collagen
  • DNA